Location of Repository

Key role for ubiquitin protein modification in TGFβ signal transduction

By Miriam De Boeck and Peter Ten Dijke

Abstract

The transforming growth factor β (TGFβ) superfamily of signal transduction molecules plays crucial roles in the regulation of cell behavior. TGFβ regulates gene transcription through Smad proteins and signals via non-Smad pathways. The TGFβ pathway is strictly regulated, and perturbations lead to tumorigenesis. Several pathway components are known to be targeted for proteasomal degradation via ubiquitination by E3 ligases. Smurfs are well known negative regulators of TGFβ, which function as E3 ligases recruited by adaptors such as I-Smads. TGFβ signaling can also be enhanced by E3 ligases, such as Arkadia, that target repressors for degradation. It is becoming clear that E3 ligases often target multiple pathways, thereby acting as mediators of signaling cross-talk. Regulation via ubiquitination involves a complex network of E3 ligases, adaptor proteins, and deubiquitinating enzymes (DUBs), the last-mentioned acting by removing ubiquitin from its targets. Interestingly, also non-degradative ubiquitin modifications are known to play important roles in TGFβ signaling. Ubiquitin modifications thus play a key role in TGFβ signal transduction, and in this review we provide an overview of known players, focusing on recent advances

Topics: Review Article
Publisher: Informa Healthcare
OAI identifier: oai:pubmedcentral.nih.gov:3339547
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev.
    2. (1999). A SMAD ubiquitin ligase targets the BMPpathway and affects embryonic pattern formation.
    3. Activation of transforming growth factor-b signaling by SUMO-1 modification of tumor suppressor Smad4/ DPC4.
    4. An RNF11:
    5. (2007). Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol.
    6. (2007). Arkadia enhances Nodal/TGF-b signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol.
    7. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-b signaling.
    8. ArkadiaamplifiesTGF-b superfamilysignalling through degradation of Smad7.
    9. (2006). Axin is a scaffoldprotein in TGF-b signaling thatpromotesdegradation of Smad7 by Arkadia.
    10. (2009). Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol.
    11. C-Ski inhibits the TGF-b signaling pathway through stabilization of inactive Smad complexes on Smadbinding elements.
    12. Cao X,WanM.Acutemyelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation. Hum Mutat.
    13. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-b.
    14. CD109-mediated degradation of TGF-b receptors and inhibition of TGF-b responses involve regulation of SMAD7 and Smurf2 localization and function.
    15. CHIP controls the sensitivity of transforming growth factor-b signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
    16. (2004). CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol.
    17. Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor b signaling.
    18. Constructing and decoding unconventional ubiquitin chains.
    19. Contextdependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells.
    20. (2002). Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell.
    21. (2003). Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell.
    22. (2006). Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-b sensitivity in vitro and in
    23. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    24. Early phase TGFb receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses.
    25. Emerging roles of deubiquitinases in cancer-associated pathways.
    26. (2006). Endocytosis: the DUB version. Trends Cell Biol.
    27. Estrogeninhibitstransforming growthfactor b signaling by promoting Smad2/3 degradation.
    28. FAM/USP9x, a deubiquitinating enzyme essential for TGFb signaling, controls Smad4 monoubiquitination.
    29. FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor.
    30. for degradation.
    31. (2005). Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell.
    32. Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays. Assay Drug Dev Technol.
    33. Integrating patterning signals:
    34. (2004). Itch E3 ligase-mediated regulation of TGF-b signaling by modulating smad2 phosphorylation. Mol Cell.
    35. (2001). Ligand-dependent degradationof Smad3by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell.
    36. ligase in substrate selection.
    37. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads.
    38. (2009). limit TGF-b signaling. Mol Cell.
    39. Molecular mechanism of the negative regulation of Smad1/5 protein by carboxyl terminus of Hsc70-interacting protein (CHIP).
    40. Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo.
    41. Negative regulation of transforming growth factor-b (TGF-b) signaling by WW domain-containing protein 1
    42. Non-Smad signaling pathways. Cell Tissue Res.
    43. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-b pathways.
    44. (2007). Patented small molecule inhibitors in the ubiquitin proteasome system. BMC Biochem.
    45. Phosphorylation of E3 ligase Smurf1 switches its substrate preference in support of axon development.
    46. Pin1 down-regulates transforming growth factor-b (TGF-b) signaling by inducing degradation of Smad proteins.
    47. (1999). Possible involvement of a novel STAMassociated molecule "AMSH" in intracellular signal transduction mediatedby cytokines.
    48. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    49. RB1CC1 positively regulates transforming growth factor-{b} signaling through the modulation of Arkadia E3 ubiquitin ligase activity.
    50. Recruitment of TIF1gamma to chromatin via its PHD fingerbromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell.
    51. regulateTGF-{b}signalingand the developmentof regulatory T cells.
    52. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation.
    53. Regulation of Kruppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-b signaling.
    54. Regulation of planar cell polarity by Smurf ubiquitin ligases.
    55. (2001). Regulation of Smad degradation and activity by
    56. RhoA ubiquitination and cell protrusive activity.
    57. Roles of mono-ubiquitinated Smad4 in the formation of Smad transcriptional complexes.
    58. SCF(b-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.
    59. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFb signalling and EMT.
    60. SIRT1 inhibits transforming growth factor b-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation.
    61. (2009). Ski co-repressor complexes maintain the basal repressed state of the TGF-b target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells.
    62. Smad-dependent and Smadindependent pathways in TGF-b family signalling.
    63. (2001). Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev.
    64. Smad4 protein stability is regulated by ubiquitin ligase SCF b-TrCP1.
    65. (1997). Smad6 inhibits signalling by the TGF-b superfamily.
    66. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF b receptor for degradation.
    67. (2011). SMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One.
    68. Smurf1 interacts with transforming growth factor-b type I receptor through Smad7 and induces receptor degradation.
    69. (2008). Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activation. Biochem Biophys Res Commun.
    70. (2000). Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-b signaling. J Biol Chem.
    71. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains.
    72. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-b signaling.
    73. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-b family signaling.
    74. TbRI/Alk5-independentTbRIIsignalingto ERK1/2in human skin cells according to distinct levels of TbRII expression.
    75. (2001). TGF-b induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol.
    76. (1997). TGF-b signalling from cell membrane to nucleus through SMAD proteins.
    77. (2001). The anaphase-promoting complex mediates TGF-b signaling by targeting SnoN for destruction. Mol Cell.
    78. The balance between acetylation and deacetylation controls Smad7 stability.
    79. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-b signalling.
    80. The MAD-related protein Smad7 associates with the TGFb receptor and functions as an antagonist of TGFb signaling.
    81. The type I TGF-b receptor engages TRAF6 to activate TAK1 in a receptor kinaseindependent manner.
    82. The type I TGF-b receptor is covalently modified and regulated by sumoylation.
    83. (1998). The ubiquitin system. Annu Rev Biochem.
    84. TRAF6 ubiquitinates TGFb type I receptor to promote its cleavage and nuclear translocation in cancer.
    85. (2010). Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma. Prostate Cancer Prostatic Dis.
    86. (2009). Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-b signaling that affects neural crest formation. Mol Biol Cell.
    87. Tumor suppressor Fbxw7 regulates TGFb signaling by targeting TGIF1 for degradation.
    88. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Mol Cell Biochem.
    89. (1999). Ubiquitin-dependent degradation of TGF-b-activated smad2. Nat Cell Biol.
    90. (2004). Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol.
    91. USP15 is a deubiquitylating enzyme for receptor-activated SMADs.
    92. USP4 targets TAK1 to downregulate TNFalpha-induced NFkappaB activation. Cell Death Differ.
    93. W r a n aJ L .R e g u l a t i o no ft h ep o l a r i t yp r o t e i nP a r 6b yT G F b Ubiquitin in TGFb signaling 163receptors controls epithelial cell plasticity.
    94. Will the ubiquitin system furnish as many drug targets as protein kinases?

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.